BACKGROUND: Alloreactive T cells and anti-human leukocyte antigen antibodies mediate transplant injury. Environmental exposures, including vaccinations, may activate the alloimmune repertoire leading to accelerated allograft injury. To test whether vaccination impacts human alloimmunity, we analyzed humoral and cellular immune reactivity in subjects undergoing influenza vaccination. METHODS: We serially obtained blood samples from 30 healthy subjects and 8 kidney and 9 lung transplant recipients who received influenza vaccination, and from 20 healthy unvaccinated controls. We measured cellular and humoral anti-influenza responses, anti-human leukocyte antigen antibodies, and alloreactive T-cell immunity (interferon-gamma ELISPOT) at 0, 2, 4, and 12 weeks after vaccination. RESULTS: Vaccination induced influenza-reactive humoral and cellular responses in control subjects and in transplant recipients. Only two of 30 vaccinated volunteers developed new alloantibodies, but none of the transplant patients. Vaccination also specifically and significantly augmented cellular alloimmunity based on reactivity to a panel of stimulators in both healthy subjects and in transplant recipients within 4 weeks of vaccination. The enhanced cellular alloresponse waned toward prevaccine levels by week 12. CONCLUSION: Our findings newly demonstrate that influenza vaccination can have a significant impact on the potency of the alloimmune repertoire. Because the strength of the alloresponse influences long-term graft function, our results suggest that further investigation of alloimmune monitoring after vaccination is needed.
BACKGROUND: Alloreactive T cells and anti-human leukocyte antigen antibodies mediate transplant injury. Environmental exposures, including vaccinations, may activate the alloimmune repertoire leading to accelerated allograft injury. To test whether vaccination impacts human alloimmunity, we analyzed humoral and cellular immune reactivity in subjects undergoing influenza vaccination. METHODS: We serially obtained blood samples from 30 healthy subjects and 8 kidney and 9 lung transplant recipients who received influenza vaccination, and from 20 healthy unvaccinated controls. We measured cellular and humoral anti-influenza responses, anti-human leukocyte antigen antibodies, and alloreactive T-cell immunity (interferon-gamma ELISPOT) at 0, 2, 4, and 12 weeks after vaccination. RESULTS: Vaccination induced influenza-reactive humoral and cellular responses in control subjects and in transplant recipients. Only two of 30 vaccinated volunteers developed new alloantibodies, but none of the transplant patients. Vaccination also specifically and significantly augmented cellular alloimmunity based on reactivity to a panel of stimulators in both healthy subjects and in transplant recipients within 4 weeks of vaccination. The enhanced cellular alloresponse waned toward prevaccine levels by week 12. CONCLUSION: Our findings newly demonstrate that influenza vaccination can have a significant impact on the potency of the alloimmune repertoire. Because the strength of the alloresponse influences long-term graft function, our results suggest that further investigation of alloimmune monitoring after vaccination is needed.
Authors: J Scharpé; P Evenepoel; B Maes; B Bammens; K Claes; A D Osterhaus; Y Vanrenterghem; W E Peetermans Journal: Am J Transplant Date: 2007-12-19 Impact factor: 8.086
Authors: Regis A Vilchez; Kenneth McCurry; James Dauber; Aldo Lacono; Bartley Griffith; John Fung; Shimon Kusne Journal: Am J Transplant Date: 2002-03 Impact factor: 8.086
Authors: Emilio D Poggio; Joshua J Augustine; Michael Clemente; Joel M Danzig; Nina Volokh; Martin S Zand; Donald E Hricik; Peter S Heeger Journal: Transplantation Date: 2007-04-15 Impact factor: 4.939
Authors: Paige M Porrett; Xueli Yuan; David F LaRosa; Patrick T Walsh; Jaeseok Yang; Wenda Gao; Peiying Li; Jidong Zhang; Javeed M Ansari; Wayne W Hancock; Mohamed H Sayegh; Maria Koulmanda; Terry B Strom; Laurence A Turka Journal: J Immunol Date: 2008-08-01 Impact factor: 5.422
Authors: Vinay Rambal; Karin Müller; Chantip Dang-Heine; Arne Sattler; Mikalai Dziubianau; Benjamin Weist; Si-Hong Luu; Alexandra Stoyanova; Peter Nickel; Andreas Thiel; Avidan Neumann; Brunhilde Schweiger; Petra Reinke; Nina Babel Journal: Med Microbiol Immunol Date: 2013-09-22 Impact factor: 3.402
Authors: L Cherkassky; M Lanning; P N Lalli; J Czerr; H Siegel; L Danziger-Isakov; T Srinivas; A Valujskikh; D A Shoskes; W Baldwin; R L Fairchild; E D Poggio Journal: Am J Transplant Date: 2011-05-12 Impact factor: 8.086
Authors: Nilufer E Broeders; Anneleen Hombrouck; Anne Lemy; Karl Martin Wissing; Judith Racapé; Karine Gastaldello; Annick Massart; Steven Van Gucht; Laura Weichselbaum; Aurelie De Mul; Bernard Brochier; Isabelle Thomas; Daniel Abramowicz Journal: Clin J Am Soc Nephrol Date: 2011-09-15 Impact factor: 8.237
Authors: Marta Crespo; Silvia Collado; Marisa Mir; Higini Cao; Francesc Barbosa; Consol Serra; Carlota Hidalgo; Anna Faura; Milagros Montero; Juan García de Lomas; Juan P Horcajada; Josep M Puig; Julio Pascual Journal: Clin J Am Soc Nephrol Date: 2011-08-18 Impact factor: 8.237
Authors: Michelle Cowan; W James Chon; Amishi Desai; Sarah Andrews; Yaohui Bai; Vic Veguilla; Jacqueline M Katz; Michelle A Josephson; Patrick C Wilson; Roger Sciammas; Anita S Chong Journal: Transplantation Date: 2014-04-27 Impact factor: 4.939